Market Cap 52.85B
Revenue (ttm) 70.99B
Net Income (ttm) 4.43B
EPS (ttm) N/A
PE Ratio 9.26
Forward PE 8.98
Profit Margin 6.24%
Debt to Equity Ratio 0.69
Volume 2,314,585
Avg Vol 3,567,286
Day's Range N/A - N/A
Shares Out 658.89M
Stochastic %K 80%
Beta 0.87
Analysts Strong Sell
Price Target $93.56

Company Profile

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance...

Industry: Insurance - Life
Sector: Financial Services
Phone: 212 578 9500
Address:
200 Park Avenue, New York, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:09 AM
$MET: The last close at $79.47 indicates a position near the 30-day moving average (MA30) of $79.5, suggesting a neutral market context. The RSI at 53.41 indicates that the stock is neither overbought nor oversold, supporting a balanced directional bias. The proximity to the 60-day high of $83.64 suggests potential upward momentum, while the low of $74.41 provides a clear support level. Suggested entry: $79.50, slightly above the MA30 for confirmation. Stop loss: $78.00, below recent support to manage risk. Targets: 1. First target at $81.00, aligning with a psychological resistance level. 2. Second target at $82.50, just below the 60-day high, allowing for potential profit-taking before reaching the high. This plan leverages current metrics to capitalize on potential upward movement while managing risk effectively. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 13 at 8:23 AM
$MET RSI: 60.94, MACD: -0.3852 Vol: 1.00, MA20: 78.08, MA50: 79.38 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:15 AM
$MET: The last close at $77.66 indicates the stock is currently positioned between the 60D high of $83.64 and the low of $74.41, suggesting a range-bound market context. The RSI at 45.09 indicates the stock is neither overbought nor oversold, providing a neutral sentiment. Directional bias leans slightly bearish, as both the 30-day MA (79.62) and the 50-day MA (79.88) are above the current price, suggesting potential resistance. Suggested entry is at $76.50, just above the 60D low, to capitalize on potential upward movement. Set a stop loss at $74.00 to limit downside risk. Targets can be set at $80.00 (near the 30-day MA) and $82.00 (approaching the 60D high), allowing for a favorable risk-reward ratio. Monitor the ATR of 1.65 for volatility adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:51 AM
$MET: The last close at $77.66 indicates the stock is currently positioned between the 60D high of $83.64 and the low of $74.41, suggesting a range-bound market context. The RSI at 45.09 indicates the stock is neither overbought nor oversold, providing a neutral sentiment. Directional bias leans slightly bearish, as both the 30-day MA (79.62) and the 50-day MA (79.88) are above the current price, suggesting potential resistance. Suggested entry is at $76.50, just above the 60D low, to capitalize on potential upward movement. Set a stop loss at $74.00 to limit downside risk. Targets can be set at $80.00 (near the 30-day MA) and $82.00 (approaching the 60D high), allowing for a favorable risk-reward ratio. Monitor the ATR of 1.65 for volatility adjustments. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 6:24 PM
Keefe, Bruyette & Woods has adjusted their stance on MetLife ( $MET ), setting the rating to Outperform with a target price of 92 → 90.
0 · Reply
Kascnef82
Kascnef82 Nov. 10 at 6:30 PM
$MET daboll out Kafka in #giants
0 · Reply
MHM7700
MHM7700 Nov. 7 at 8:23 PM
$MET 11/21 75p $1.05
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:39 PM
Wells Fargo updates rating for MetLife ( $MET ) to Overweight, target set at 96 → 92.
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 6:46 PM
UBS has updated their rating for MetLife ( $MET ) to Buy with a price target of 95.
0 · Reply
AshHydrogen
AshHydrogen Nov. 4 at 10:55 AM
$PLTR What did $NVDA say??? https://media.stocktwits-cdn.com/api/3/media/8400841/medium.png $MSFT $MET $ORCL BTMFD
0 · Reply
Latest News on MET
MetLife, Inc. (MET) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 12:36 PM EST - 8 days ago

MetLife, Inc. (MET) Q3 2025 Earnings Call Transcript


MetLife quarterly profit rises on investment gains

Nov 5, 2025, 6:00 PM EST - 8 days ago

MetLife quarterly profit rises on investment gains


MetLife Announces 3Q 2025 Results

Nov 5, 2025, 4:15 PM EST - 8 days ago

MetLife Announces 3Q 2025 Results


MetLife Declares Fourth Quarter 2025 Common Stock Dividend

Oct 7, 2025, 4:15 PM EDT - 5 weeks ago

MetLife Declares Fourth Quarter 2025 Common Stock Dividend


MetLife Announces Full Redemption of Series G Preferred Stock

Sep 2, 2025, 4:15 PM EDT - 2 months ago

MetLife Announces Full Redemption of Series G Preferred Stock


MetLife Declares Third Quarter 2025 Preferred Stock Dividends

Aug 15, 2025, 4:15 PM EDT - 3 months ago

MetLife Declares Third Quarter 2025 Preferred Stock Dividends


MetLife, Inc. (MET) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 3:04 PM EDT - 3 months ago

MetLife, Inc. (MET) Q2 2025 Earnings Call Transcript


MetLife's profit falls on less favorable underwriting margins

Aug 6, 2025, 6:50 PM EDT - 3 months ago

MetLife's profit falls on less favorable underwriting margins


MetLife Announces 2Q 2025 Results

Aug 6, 2025, 4:15 PM EDT - 3 months ago

MetLife Announces 2Q 2025 Results


Buy or Sell MetLife Stock Ahead of Earnings?

Aug 4, 2025, 6:35 AM EDT - 3 months ago

Buy or Sell MetLife Stock Ahead of Earnings?


MetLife Names Adrienne O'Neill as Chief Accounting Officer

Jul 30, 2025, 8:30 AM EDT - 3 months ago

MetLife Names Adrienne O'Neill as Chief Accounting Officer


MetLife to Hold Conference Call for Second Quarter 2025 Results

Jul 9, 2025, 4:15 PM EDT - 4 months ago

MetLife to Hold Conference Call for Second Quarter 2025 Results


The Best Financial Stocks to Buy

Jul 8, 2025, 4:59 PM EDT - 4 months ago

The Best Financial Stocks to Buy

BX CG


MetLife Declares Third Quarter 2025 Common Stock Dividend

Jul 8, 2025, 4:15 PM EDT - 4 months ago

MetLife Declares Third Quarter 2025 Common Stock Dividend


MetLife and Nayya Expand Access to Upwise via Workday Marketplace

Jun 23, 2025, 10:00 AM EDT - 5 months ago

MetLife and Nayya Expand Access to Upwise via Workday Marketplace


MetLife Investment Management Names Brian Funk President

Jun 18, 2025, 4:15 PM EDT - 5 months ago

MetLife Investment Management Names Brian Funk President


MetLife Names Jane Slusark as Chief Communications Officer

May 19, 2025, 1:01 PM EDT - 6 months ago

MetLife Names Jane Slusark as Chief Communications Officer


MetLife Declares Second Quarter 2025 Preferred Stock Dividends

May 15, 2025, 4:15 PM EDT - 6 months ago

MetLife Declares Second Quarter 2025 Preferred Stock Dividends


MetLife's New Frontier: Hidden Growth Opportunities

May 3, 2025, 7:30 AM EDT - 6 months ago

MetLife's New Frontier: Hidden Growth Opportunities


MetLife Investment Management Announces Driscoll Retirement

May 2, 2025, 8:30 AM EDT - 7 months ago

MetLife Investment Management Announces Driscoll Retirement


MetLife, Inc. (MET) Q1 2025 Earnings Call Transcript

May 1, 2025, 1:01 PM EDT - 7 months ago

MetLife, Inc. (MET) Q1 2025 Earnings Call Transcript


MetLife Profit, Revenue Rises on Growth in Premiums and Fees

Apr 30, 2025, 5:28 PM EDT - 7 months ago

MetLife Profit, Revenue Rises on Growth in Premiums and Fees


PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:09 AM
$MET: The last close at $79.47 indicates a position near the 30-day moving average (MA30) of $79.5, suggesting a neutral market context. The RSI at 53.41 indicates that the stock is neither overbought nor oversold, supporting a balanced directional bias. The proximity to the 60-day high of $83.64 suggests potential upward momentum, while the low of $74.41 provides a clear support level. Suggested entry: $79.50, slightly above the MA30 for confirmation. Stop loss: $78.00, below recent support to manage risk. Targets: 1. First target at $81.00, aligning with a psychological resistance level. 2. Second target at $82.50, just below the 60-day high, allowing for potential profit-taking before reaching the high. This plan leverages current metrics to capitalize on potential upward movement while managing risk effectively. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 13 at 8:23 AM
$MET RSI: 60.94, MACD: -0.3852 Vol: 1.00, MA20: 78.08, MA50: 79.38 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:15 AM
$MET: The last close at $77.66 indicates the stock is currently positioned between the 60D high of $83.64 and the low of $74.41, suggesting a range-bound market context. The RSI at 45.09 indicates the stock is neither overbought nor oversold, providing a neutral sentiment. Directional bias leans slightly bearish, as both the 30-day MA (79.62) and the 50-day MA (79.88) are above the current price, suggesting potential resistance. Suggested entry is at $76.50, just above the 60D low, to capitalize on potential upward movement. Set a stop loss at $74.00 to limit downside risk. Targets can be set at $80.00 (near the 30-day MA) and $82.00 (approaching the 60D high), allowing for a favorable risk-reward ratio. Monitor the ATR of 1.65 for volatility adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:51 AM
$MET: The last close at $77.66 indicates the stock is currently positioned between the 60D high of $83.64 and the low of $74.41, suggesting a range-bound market context. The RSI at 45.09 indicates the stock is neither overbought nor oversold, providing a neutral sentiment. Directional bias leans slightly bearish, as both the 30-day MA (79.62) and the 50-day MA (79.88) are above the current price, suggesting potential resistance. Suggested entry is at $76.50, just above the 60D low, to capitalize on potential upward movement. Set a stop loss at $74.00 to limit downside risk. Targets can be set at $80.00 (near the 30-day MA) and $82.00 (approaching the 60D high), allowing for a favorable risk-reward ratio. Monitor the ATR of 1.65 for volatility adjustments. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 6:24 PM
Keefe, Bruyette & Woods has adjusted their stance on MetLife ( $MET ), setting the rating to Outperform with a target price of 92 → 90.
0 · Reply
Kascnef82
Kascnef82 Nov. 10 at 6:30 PM
$MET daboll out Kafka in #giants
0 · Reply
MHM7700
MHM7700 Nov. 7 at 8:23 PM
$MET 11/21 75p $1.05
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:39 PM
Wells Fargo updates rating for MetLife ( $MET ) to Overweight, target set at 96 → 92.
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 6:46 PM
UBS has updated their rating for MetLife ( $MET ) to Buy with a price target of 95.
0 · Reply
AshHydrogen
AshHydrogen Nov. 4 at 10:55 AM
$PLTR What did $NVDA say??? https://media.stocktwits-cdn.com/api/3/media/8400841/medium.png $MSFT $MET $ORCL BTMFD
0 · Reply
ZacksResearch
ZacksResearch Nov. 3 at 6:38 PM
$MET gears up for Q3 earnings with bullish estimates 📈 Forecasts point to strong revenue and earnings growth even as cost pressures linger — a solid setup heading into the print. Full preview and key numbers here 👉 https://www.zacks.com/stock/news/2783775/metlife-to-report-q3-earnings-what-do-the-key-estimates-say?cid=sm-stocktwits-2-2783775-teaser-19193&ADID=SYND_STOCKTWITS_TWEET_2_2783775_TEASER_19193
0 · Reply
ZacksResearch
ZacksResearch Nov. 3 at 5:38 PM
$MET Q3 earnings preview: Can MetLife break its losing streak? 📉 Despite missing estimates four quarters in a row, MET's Q3 earnings are projected to show a 20.7% YoY growth, with revenues expected to grow 7% YoY. However, its Earnings ESP of -0.23% suggests a miss could be on the horizon again. See the full analysis here 👉 https://www.zacks.com/stock/news/2783775/metlife-to-report-q3-earnings-what-do-the-key-estimates-say?cid=sm-stocktwits-2-2783775-body-19172&ADID=SYND_STOCKTWITS_TWEET_2_2783775_BODY_19172
0 · Reply
__SquuezedChronometer_
__SquuezedChronometer_ Nov. 2 at 11:09 AM
Next major retail squeeze candidate right here $MET $EMR $CAI $MNDY .
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 29 at 3:53 PM
$MET Share Price: $78.99 Contract Selected: Mar 20, 2026 $80 Calls Buy Zone: $3.48 – $4.30 Target Zone: $6.35 – $7.76 Potential Upside: 72% ROI Time to Expiration: 141 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Oct. 27 at 11:00 AM
$ALL trading at $193 while $MET at $79. ALL showing -31% volume vs avg, MET -28%. Insurance sector in focus - which stock will weather the storm better?
0 · Reply
Kascnef82
Kascnef82 Oct. 26 at 7:11 PM
$LNC eagles look good but they’re hurting my giants $MET
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Oct. 25 at 9:07 AM
$MET trading at $79 with volume 28% below average, while $LNC priced at $40 with volume 54% below average. MET showing relative strength with a higher price and less volume decline. Are investors favoring the Insurance sector amidst market uncertainty?
0 · Reply
Estimize
Estimize Oct. 23 at 10:15 PM
Wall St is expecting 2.32 EPS for $MET Q3 [Reporting 11/05 AMC] http://www.estimize.com/intro/met?chart=historical&metric_name=eps&utm_cont
0 · Reply
Bastoni419
Bastoni419 Oct. 22 at 3:09 PM
0 · Reply
CryptoLite
CryptoLite Oct. 22 at 3:06 PM
I’ve been around long enough to see hype projects come and go the ones that pump hard, fade fast, and leave nothing behind. But modular DeFi platforms like Meteora feel different. I noticed that with the $MET token launch lining up with the BG listing, there’s real potential for new liquidity and users to flow in at the perfect time. If Meteora keeps executing, this could be one of those tokens that quietly grows into a major player while everyone’s distracted by memecoins. I’m keeping this one on my watchlist for the long haul.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 4:32 AM
Enter: $MET NOV 21 2025 $80 CALLS Buy in Price: $2.10 - $2.30 Take Profit: $3.97 Stop Bleeding: $1.85 ROI Potential: 89% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 20 at 4:29 PM
$MET Share Price: $78.84 Contract Selected: Mar 20, 2026 $80 Calls Buy Zone: $3.82 – $4.73 Target Zone: $6.69 – $8.18 Potential Upside: 65% ROI Time to Expiration: 150 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply